Lupron (leuprolide acetate) is a hormone-suppressing medication used to treat a range of conditions, including advanced prostate cancer, endometriosis, uterine fibroids, early puberty in children, and as part of fertility treatments. It works by shutting down the body’s production of sex hormones like testosterone and estrogen, which makes it useful whenever those hormones are driving a medical problem.
How Lupron Works
Lupron mimics a natural brain hormone called GnRH, which controls the release of sex hormones. When you first take it, Lupron actually causes a brief spike in testosterone or estrogen. But with continuous use, it overwhelms the system and causes the brain to stop signaling the ovaries or testes to produce those hormones. The result is a dramatic drop in sex hormone levels, sometimes called a “medical castration” in the context of prostate cancer or a temporary, reversible menopause-like state in women.
This two-phase pattern matters clinically. The initial hormone surge can temporarily worsen symptoms for the first week or two before suppression kicks in, which is something patients are typically warned about before starting treatment.
Prostate Cancer
Prostate cancer cells depend on testosterone to grow. Lupron cuts off that fuel supply by suppressing testosterone production, which can slow tumor growth or cause cancer cells to die. It is one of the most commonly prescribed hormone therapies for advanced and metastatic prostate cancer, often used alongside other treatments.
For prostate cancer, Lupron is available as a long-acting injection given on various schedules: once a month, every three months, every four months, or every six months, depending on the formulation. This flexibility lets doctors tailor the schedule to a patient’s needs and preferences. Because of the initial testosterone surge, doctors sometimes prescribe a short course of an additional medication to block testosterone’s effects during the first few weeks.
Endometriosis
Endometriosis is tissue similar to the uterine lining growing outside the uterus, causing chronic pain. Since this tissue responds to estrogen, Lupron helps by dropping estrogen levels low enough to shrink the growths and reduce pain. The FDA-approved treatment course is six months, given as either a monthly or every-three-month injection.
If symptoms return after that initial course, one additional six-month round of treatment may be considered, but only in combination with a progesterone-type add-back medication (norethindrone acetate). Retreatment beyond that second course is not recommended, largely because of the impact on bone health. Bone density testing is recommended before any retreatment to make sure values are still within a normal range.
Uterine Fibroids
Lupron is not a long-term treatment for fibroids. Instead, it is used as a short-term bridge before surgery. By shrinking fibroids and reducing heavy bleeding, it helps women with fibroid-related anemia build up their blood counts before a procedure. The typical course is a single three-month injection or up to three monthly injections. It is always used alongside iron therapy to correct the anemia.
Central Precocious Puberty
When children begin puberty abnormally early, before age 8 in girls or 10 in boys, Lupron can pause the process. It suppresses the hormones driving development and gives children time to reach a more typical age for puberty. Treatment usually continues from the time of diagnosis until the age when puberty would normally begin, which can mean several years of injections.
A pediatric-specific formulation (Lupron Depot-Ped) is available as a monthly, every-three-month, or every-six-month injection. Because treatment duration can be long and injections are stressful for young children, the longer-acting formulations were developed specifically to reduce the number of shots needed.
Puberty Suppression for Gender-Diverse Youth
Lupron is also used as a puberty blocker for transgender and gender-diverse adolescents. It pauses the physical changes of puberty, giving young people and their families more time to make decisions about their care. The medication is only started after puberty has already begun, not before, and it is prescribed and monitored by a specialist experienced with this class of drugs.
Regular blood tests and follow-up appointments are standard during treatment to check that the medication is working and to monitor for side effects. In most cases, informed consent from both the patient and a parent or guardian is required.
Fertility Treatments
In IVF cycles, Lupron plays a different role. It is used to suppress the body’s natural hormone cycle so that fertility specialists can control follicle development more precisely. By quieting the pituitary gland’s signals to the ovaries, Lupron allows injected fertility medications to stimulate a more uniform development of multiple egg-containing follicles. In some IVF protocols, a small dose of Lupron is also used as an ovulation trigger instead of other medications.
Side Effects and Bone Health
Most side effects of Lupron stem directly from the hormone suppression it causes. Hot flashes are the most common complaint across nearly all patient groups. Other frequent effects include mood changes, headaches, decreased sex drive, fatigue, and injection site reactions. In men being treated for prostate cancer, the drop in testosterone can also cause weight gain, muscle loss, and sexual dysfunction. In women, the low-estrogen state can mimic menopause with vaginal dryness, mood swings, and joint stiffness.
Bone loss is one of the more significant safety concerns with longer use. In endometriosis patients, vertebral bone density drops by an average of 3.2% after six months of treatment. In fibroid patients treated for three months, the average loss is 2.7%. This is why treatment courses for these conditions are kept short and why add-back therapy with a progesterone-type medication is recommended during retreatment. Patients who already have risk factors for osteoporosis, such as smoking, heavy alcohol use, a strong family history, or long-term use of certain other medications, need careful evaluation before starting Lupron.
For children and adolescents on Lupron, bone density is monitored throughout treatment. The effects on bone are generally considered reversible once the medication is stopped and normal hormone production resumes.
How It Is Given
Lupron comes in several forms. Daily subcutaneous injections (shots just under the skin) exist but are rarely used today. The most common formulations are long-acting “depot” injections given into a muscle or under the skin on a set schedule. Depending on the condition being treated, options range from monthly to every six months. An implant placed under the skin of the upper arm, typically replaced once a year, is another option used primarily for puberty suppression.
The variety of formulations means the medication can be matched to the treatment timeline. A woman with fibroids may need only a single three-month injection before surgery, while a man with prostate cancer may receive injections every few months for years.